Aurora Cannabis (ACB) EBIT Growth (1y) (2018 - 2026)
Aurora Cannabis (ACB) EBIT Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -150.77% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -10.00% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -0.93% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -9.25% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -97.30% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 4.05% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 12.73% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Aurora Cannabis | 233.45 Mn | 161.14 Mn | 25.75 Mn | 73.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117.78% |
| Dec 31, 2025 | -46.83% |
| Sep 30, 2025 | 262.57% |
| Jun 30, 2025 | -51.54% |
| Mar 31, 2025 | -898.92% |
| Dec 31, 2024 | 304.13% |
| Sep 30, 2024 | 78.28% |
| Jun 30, 2024 | 99.98% |
| Dec 31, 2023 | 90.00% |
| Sep 30, 2023 | 90.29% |
| Jun 30, 2023 | -10,000.51% |
| Dec 31, 2022 | -191.88% |
| Sep 30, 2022 | -165.77% |
| Jun 30, 2022 | -14.74% |
| Mar 31, 2022 | 49.41% |
| Dec 31, 2021 | -22.65% |
| Sep 30, 2021 | 1.52% |
| Jun 30, 2021 | 92.37% |
| Mar 31, 2021 | -81.20% |
| Dec 31, 2020 | -139.83% |